S&P 500   5,063.58 (-0.12%)
DOW   38,905.62 (-0.42%)
QQQ   436.67 (+0.03%)
AAPL   180.74 (-0.23%)
MSFT   405.07 (-0.61%)
META   483.44 (+0.35%)
GOOGL   137.52 (-0.04%)
AMZN   174.07 (-0.38%)
TSLA   200.66 (+0.63%)
NVDA   791.94 (+0.13%)
NIO   5.76 (+1.95%)
AMD   177.98 (+1.12%)
BABA   77.71 (+1.57%)
T   16.62 (+0.12%)
F   12.04 (+0.75%)
MU   91.34 (+2.10%)
CGC   3.56 (+2.59%)
GE   153.97 (-0.52%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.97 (-0.77%)
PYPL   59.94 (+1.03%)
XOM   104.31 (+0.06%)
S&P 500   5,063.58 (-0.12%)
DOW   38,905.62 (-0.42%)
QQQ   436.67 (+0.03%)
AAPL   180.74 (-0.23%)
MSFT   405.07 (-0.61%)
META   483.44 (+0.35%)
GOOGL   137.52 (-0.04%)
AMZN   174.07 (-0.38%)
TSLA   200.66 (+0.63%)
NVDA   791.94 (+0.13%)
NIO   5.76 (+1.95%)
AMD   177.98 (+1.12%)
BABA   77.71 (+1.57%)
T   16.62 (+0.12%)
F   12.04 (+0.75%)
MU   91.34 (+2.10%)
CGC   3.56 (+2.59%)
GE   153.97 (-0.52%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.97 (-0.77%)
PYPL   59.94 (+1.03%)
XOM   104.31 (+0.06%)
S&P 500   5,063.58 (-0.12%)
DOW   38,905.62 (-0.42%)
QQQ   436.67 (+0.03%)
AAPL   180.74 (-0.23%)
MSFT   405.07 (-0.61%)
META   483.44 (+0.35%)
GOOGL   137.52 (-0.04%)
AMZN   174.07 (-0.38%)
TSLA   200.66 (+0.63%)
NVDA   791.94 (+0.13%)
NIO   5.76 (+1.95%)
AMD   177.98 (+1.12%)
BABA   77.71 (+1.57%)
T   16.62 (+0.12%)
F   12.04 (+0.75%)
MU   91.34 (+2.10%)
CGC   3.56 (+2.59%)
GE   153.97 (-0.52%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.97 (-0.77%)
PYPL   59.94 (+1.03%)
XOM   104.31 (+0.06%)
S&P 500   5,063.58 (-0.12%)
DOW   38,905.62 (-0.42%)
QQQ   436.67 (+0.03%)
AAPL   180.74 (-0.23%)
MSFT   405.07 (-0.61%)
META   483.44 (+0.35%)
GOOGL   137.52 (-0.04%)
AMZN   174.07 (-0.38%)
TSLA   200.66 (+0.63%)
NVDA   791.94 (+0.13%)
NIO   5.76 (+1.95%)
AMD   177.98 (+1.12%)
BABA   77.71 (+1.57%)
T   16.62 (+0.12%)
F   12.04 (+0.75%)
MU   91.34 (+2.10%)
CGC   3.56 (+2.59%)
GE   153.97 (-0.52%)
DIS   108.30 (+0.58%)
AMC   4.63 (+4.04%)
PFE   26.97 (-0.77%)
PYPL   59.94 (+1.03%)
XOM   104.31 (+0.06%)

Mirum Pharmaceuticals (MIRM) Earnings Date, Estimates & Call Transcripts

$29.08
+0.02 (+0.07%)
(As of 12:39 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

MIRM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MIRM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Mirum Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.13)$0.07($0.03) 
Q2 20242$0.06$0.10$0.08 
Q3 20242$0.11$0.15$0.13 
Q4 20242$0.11$0.32$0.22 
FY 20248$0.15$0.64 $0.40

MIRM Earnings Date and Information

Mirum Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, February 28th, 2024. Mirum Pharmaceuticals will be holding an earnings conference call on Wednesday, February 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Mirum Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/28/2024
Confirmed)
-------  
11/2/2023Q3 2023($0.64)($0.57)+$0.07($0.57)$34.31 million$47.73 million
8/3/2023Q2 2023($0.81)($0.92)($0.11)$0.10$30.00 million$37.50 million
5/4/2023Q1 2023($0.96)($0.80)+$0.16($0.80)$30.58 million$31.60 million
3/8/2023Q4 2022($0.98)($0.99)($0.01)($0.99)$24.99 million$27.91 million
11/9/2022Q3 2022($1.05)($1.02)+$0.03($1.02)$21.16 million$18.78 million
8/4/2022Q2 2022($1.05)($0.84)+$0.21($0.84)$15.67 million$17.48 million  
5/5/2022Q1 2022($1.39)($1.17)+$0.22($1.17)$8.68 million$12.89 million    
3/9/2022Q4 2021($0.61)($0.92)($0.31)($3.75)$76.60 million$3.14 million
11/15/2021Q3 2021($1.63)($1.55)+$0.08($1.55)$5.00 million$5.00 million    
8/5/2021Q2 2021($0.41)($1.45)($1.04)($1.45)$29.00 million$11.00 million  
5/6/2021Q1 2021($0.67)($1.68)($1.01)($1.68)--  
3/8/2021Q4 2020($0.73)($1.43)($0.70)($1.43)--












Mirum Pharmaceuticals Earnings - Frequently Asked Questions

When is Mirum Pharmaceuticals's earnings date?

Mirum Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Wednesday, February 28th, 2024. Learn more on MIRM's earnings history.

How much revenue does Mirum Pharmaceuticals generate each year?

Mirum Pharmaceuticals (NASDAQ:MIRM) has a recorded annual revenue of $77.06 million.

How much profit does Mirum Pharmaceuticals generate each year?

Mirum Pharmaceuticals (NASDAQ:MIRM) has a recorded net income of -$135.66 million. MIRM has generated -$4.30 earnings per share over the last four quarters.

What is Mirum Pharmaceuticals's EPS forecast for next year?

Mirum Pharmaceuticals's earnings are expected to grow from ($2.47) per share to ($0.38) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MIRM) was last updated on 2/27/2024 by MarketBeat.com Staff